#USA #Kessler Topaz #Radnor #Securities Law #Celcuity Inc.

Kessler Topaz Meltzer & Check Invites Celcuity Inc. Investors to Contact

In a recent development, the law firm Kessler Topaz Meltzer & Check, LLP has commenced an investigation into Celcuity Inc. (NASDAQ: CELC). This inquiry is aimed at identifying possible breaches of federal securities laws that may have impacted investors negatively. The focus of the investigation centers on individuals who purchased Celcuity securities and subsequently encountered substantial financial losses.

Recent Announcements by Celcuity Inc.

On July 14, 2026, Celcuity released a statement that revealed it had received FDA approval for its breast cancer treatment, Revtorpyk (gedatolisib). This approval was initially expected to herald a product launch; however, the timeline has since been pushed back to late Q3 2026. Analysts have expressed concerns regarding this delay, questioning whether Celcuity can meet its revised launch expectations. An analyst from Stifel acknowledged that the new timeline appeared unusually protracted compared to prior announcements, while another from Leerink noted the expectation of a quicker launch following the FDA's approval.

Impact on Stock Price

Following the announcement about the delayed launch of Revtorpyk, Celcuity Inc.’s stock witnessed a sharp decline, plummeting more than 17%. This significant drop has raised alarms among investors, prompting many to consider their legal options. Kessler Topaz Meltzer & Check is inviting impacted investors to reach out and discuss their legal rights in light of this situation. Investors who have faced losses from purchasing Celcuity shares may have viable claims under securities laws and are encouraged to gather information necessary to pursue legal action.

Legal Support Awareness

The firm emphasizes that consultation is available without any associated costs or obligations. Interested parties can easily provide their details through a specified link for further assistance in understanding their legal rights and options. Kessler Topaz Meltzer & Check stands out as a prominent name in securities litigation, recognized for handling class action suits aimed at protecting investor interest.

About Kessler Topaz Meltzer & Check, LLP

Kessler Topaz Meltzer & Check, LLP is highly regarded in the realm of securities fraud litigation, representing both individual and institutional investors alike. The firm has established a reputation for obtaining substantial recoveries for victims of securities fraud, evidenced by its accolades and rankings in leading legal directories, such as Chambers & Partners and The Legal 500. With offices located in Pennsylvania and California, Kessler Topaz has secured over $25 billion for clients over its operational history.

As such, the firm is prepared to extend its expertise to those affected by Celcuity’s recent challenges, ensuring that investors receive the representation they need in navigating complex securities laws.

For more information, potential clients can reach out to Jonathan Naji, Esq. at Kessler Topaz Meltzer & Check, LLP. The firm's commitment to investor protection underscores its ongoing mission to hold corporations accountable and ensure transparency and integrity within the financial markets.